Clinical Trial Update: Mass Balance Study of [14C] LPM3770164 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 mass balance pharmacokinetic study of [14C] LPM3770164 in healthy participants, sponsored by Luye Pharma Group Ltd.; Huntington disease is listed as the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• LPM3770164

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Huntington Disease | Phase 1 | Status: NOT_YET_RECRUITING